FTO (Freedom to Operate) in the Pharmaceutical Industry
Seiten
2018
Nomos (Verlag)
978-3-8487-5221-8 (ISBN)
Nomos (Verlag)
978-3-8487-5221-8 (ISBN)
FTO licensing in the pharmaceutical industry deserves special consideration because of the large economic scale of the market, expensive cost of R&D, extremely low success rate, and easy duplication of the drug. Taking these unique aspects into consideration, the author first explaines how to perform a good FTO search and conclude an appropriate FTO licensing agreement, and then points out two issues; (i) the issue of FTO licensing and EU competition, especially the unreasonable application of the Guideline, and (ii) the issue of FTO licensing and differentiating between a bio venture company and a pharmaceutical company. Solutions for these issues are proposed.The author is Hirotaka Nonaka; an attorney-at-law and patent attorney in Tokyo, Japan, handling particularly IP-related disputes and consulting.
| Erscheinungsdatum | 21.08.2018 |
|---|---|
| Reihe/Serie | Munich Intellectual Property Law Center – MIPLC ; 34 |
| Sprache | englisch |
| Maße | 153 x 227 mm |
| Gewicht | 135 g |
| Themenwelt | Recht / Steuern ► EU / Internationales Recht |
| Recht / Steuern ► Privatrecht / Bürgerliches Recht ► Medizinrecht | |
| Recht / Steuern ► Wirtschaftsrecht ► Urheberrecht | |
| Schlagworte | antitrust law • EU Competition Law • Freedom of Operate • Freedom to operate • FTO • FTO-licensing market • license • Patent • Pharmaceutical • Pharmaceutical Industry |
| ISBN-10 | 3-8487-5221-2 / 3848752212 |
| ISBN-13 | 978-3-8487-5221-8 / 9783848752218 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
